BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 83 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $42,000 | -50.6% | 32,679 | -60.0% | 0.00% | – |
| Q3 2019 | $85,000 | -78.0% | 81,791 | -64.2% | 0.00% | – |
| Q2 2019 | $386,000 | -66.3% | 228,263 | -33.0% | 0.00% | -100.0% |
| Q1 2019 | $1,146,000 | +19.0% | 340,778 | +3.2% | 0.00% | 0.0% |
| Q4 2018 | $963,000 | -43.8% | 330,195 | +18.5% | 0.00% | 0.0% |
| Q3 2018 | $1,714,000 | -10.4% | 278,600 | +7.4% | 0.00% | 0.0% |
| Q2 2018 | $1,912,000 | +65.1% | 259,290 | +46.7% | 0.00% | 0.0% |
| Q1 2018 | $1,158,000 | +25.3% | 176,707 | +60.6% | 0.00% | 0.0% |
| Q4 2017 | $924,000 | -6.7% | 110,028 | +28.3% | 0.00% | 0.0% |
| Q3 2017 | $990,000 | -9.0% | 85,782 | -8.1% | 0.00% | 0.0% |
| Q2 2017 | $1,088,000 | +30.8% | 93,323 | +38.2% | 0.00% | 0.0% |
| Q1 2017 | $832,000 | -6.1% | 67,548 | +3.6% | 0.00% | 0.0% |
| Q4 2016 | $886,000 | -30.8% | 65,200 | +1.2% | 0.00% | 0.0% |
| Q3 2016 | $1,281,000 | +55.3% | 64,442 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $825,000 | +73.7% | 63,826 | +25.4% | 0.00% | – |
| Q1 2016 | $475,000 | -50.2% | 50,909 | +8.3% | 0.00% | -100.0% |
| Q4 2015 | $953,000 | -60.5% | 47,029 | -71.7% | 0.00% | -50.0% |
| Q3 2015 | $2,412,000 | +37.5% | 166,070 | +101.3% | 0.00% | +100.0% |
| Q2 2015 | $1,754,000 | +24.2% | 82,502 | +35.2% | 0.00% | 0.0% |
| Q1 2015 | $1,412,000 | -38.1% | 61,000 | -38.4% | 0.00% | 0.0% |
| Q4 2014 | $2,281,000 | – | 99,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|